Actively Recruiting
Improving Medication Prescription in the Context of Advance Care Planning for Patients Receiving Long Term Nursing Home Care
Led by Amsterdam UMC, location VUmc · Updated on 2024-12-12
450
Participants Needed
7
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Amsterdam UMC, location VUmc
Lead Sponsor
Z
ZonMw: The Netherlands Organisation for Health Research and Development
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate how training healthcare professionals in medication assessment affects the medication use of nursing home residents aged 65 and older who have a limited life expectancy of less than 1.5 to 2 years. The study focuses on tailoring medication to the palliative treatment goals of these residents and is designed as a cluster randomized controlled trial involving six nursing home organizations and approximately 450 patients. The research is led by Amsterdam UMC and spans one year and three months starting in September 2024. The intervention involves a training program for healthcare professionals, including medical practitioners, pharmacists, and care workers, to align prescriptions with treatment goals established through advance care planning conversations. This training has two parts: medication assessment using specialized criteria and advance care planning. Professionals in the intervention group receive this training along with supporting tools and educational materials, while the control group continues with usual care. Data collection occurs at baseline, 6 months, and 12 months. Participants will be assessed through medication reviews and questionnaires measuring involvement in decision-making, quality of life, and other health outcomes such as falls and hospital admissions. The main outcome is identifying potential under- or overprescribing of medications. The study also monitors experienced involvement in medication decisions, pain levels, and death rates. Participants stay in the study for at least one year, with evaluations at multiple time points to track changes.
CONDITIONS
Brief Title
Improved Prescribing for Older Nursing Home Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years and above
- Living at long term care wards in nursing homes
- Living at a long term care ward for at least 4 weeks before start of the study
You will not qualify if you...
- Temporary nursing home patients (such as for geriatric rehabilitation or hospice care)
- Life expectancy less than 4 weeks
- Life expectancy clearly greater than 1.5 to 2 years (e.g., patients with Huntington's disease)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 12 months
Participants in the experimental group receive in-house training for healthcare professionals, including medication assessment using the ReNeWAL criteria and advance care planning discussions to align prescriptions with treatment goals. This includes supporting tools and educational materials.
Duration - 12 months
Participants are assessed for medication prescribing quality and involvement in decision-making at baseline, 2-4 weeks after the medication review, 6 months, and 12 months.
Assessments at baseline, 2-4 weeks, 6 months, and 12 months
Trial Site Locations
Total: 7 locations
1
Zorggroep Apeldoorn, location Randerode, De Hofstede and De Windkanter
Apeldoorn, Gelderland, Netherlands, 7334DV
Active, Not Recruiting
2
Zorggroep Noordwest-Veluwe, locaties Weideheem en de Arcade
Harderwijk, Gelderland, Netherlands, 3844 JW
Active, Not Recruiting
3
Cordaan, location Nieuw Vredenburgh
Amsterdam, North Holland, Netherlands, 1057 DZ
Actively Recruiting
4
Amaris, Location Alporti and Rubina
Hilversum, North Holland, Netherlands, 1215 SE
Active, Not Recruiting
5
AxionContinu, location Isselwaerde and de Schutse
IJsselstein, Utrecht, Netherlands, 3401 BN
Actively Recruiting
6
Zorgspectrum, location de Plataan
Vianen, Utrecht, Netherlands, 4133 GX
Actively Recruiting
7
Dignis, location de Veldspaat
Groningen, Netherlands, 9743XV
Active, Not Recruiting
Research Team
M
Marlies Dijk, MD
E
Eefje Sizoo, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here